Adiponectin: An adipokine linking adipocytes and type 2 diabetes in humans

被引：50

作者：

Hara K. ^{[1
]}

Yamauchi T. ^{[1
]}

Kadowaki T. ^{[1
]}

机构：

[1] Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-8655

来源：

Current Diabetes Reports | 2005年 / 5卷 / 2期

关键词：

Insulin Resistance; Metabolic Syndrome; Adiponectin Level; Serum Adiponectin; Plasma Adiponectin;

D O I：

10.1007/s11892-005-0041-0

中图分类号：

学科分类号：

摘要：

Adipocyte-derived adiponectin is an insulin-sensitizing and antiatherosclerotic hormone, and replenishment of adiponectin in animal models ameliorated insulin resistance and atherosclerosis. In humans, recent studies have demonstrated that adiponectin level is a good predictor of developing type 2 diabetes and coronary artery disease. Decreasing level of adiponectin is caused by the interaction between genetic factors, such as single nucleotide polymorphisms in the adiponectin gene, and environmental factors, such as high-fat diet. Agents that increase blood level of adiponectin or enhance the actions of adiponectin can be an ideal medicine for ameliorating insulin resistance and type 2 diabetes. Copyright © 2005 by Current Science Inc.

引用

页码：136 / 140

页数：4

共 35 条

[1] Weyer C., Funahashi T., Tanaka S., Et al., Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia, J. Clin. Endocrinol. Metab., 86, pp. 1930-1935, (2001)
[2] Hotta K., Funahashi T., Bodkin N.L., Et al., Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys, Diabetes, 501, pp. 126-133, (2001)
[3] Arita Y., Kihara S., Ouchi N., Et al., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity, Biochem. Biophys. Res. Commun., 257, pp. 79-83, (1999)
[4] Yamauchi T., Kamon J., Waki H., Et al., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity, Nat. Med., 7, pp. 941-946, (2001)
[5] Mori Y., Otabe S., Dina C., Et al., Genome-wide search for type 2 diabetes susceptibility genes in Japanese affected sibpairs. Autosomal scan supplemented with markers for 12 transcription factor genes and adiponectin gene, Diabetes, 51, pp. 536-540, (2002)
[6] Kissebah A.H., Sonnenberg G.E., Myklebust J., Et al., Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome, Proc. Natl. Acad. Sci. U. S. A., 97, pp. 14478-14483, (2000)
[7] Yamauchi T., Waki H., Kamon J., Et al., Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes, J. Clin. Invest., 108, pp. 1001-1113, (2001)
[8] Kubota N., Terauchi Y., Miki H., Et al., PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance, Mol. Cell, 4, pp. 597-609, (1999)
[9] Hara K., Boutin P., Mori Y., Et al., Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population, Diabetes, 51, pp. 536-540, (2002)
[10] Kadowaki T., Hara K., Yamauchi T., Et al., Molecular mechanism of insulin resistance and obesity, Exp. Biol. Med. (Maywood), 228, pp. 1111-1117, (2003)

← 1 2 3 4 →